SCHEMBL6274560

SCHEMBL6274560

CCOc1c(O)c2c(OCC(O)CO)cccc2oc1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR35 Q9HC97 2/20 0.45
▸ LMNA P02545 2/20 0.45
▸ TDP1 Q9NUW8 2/20 0.45
▸ NQO1 P15559 1/20 0.43
▸ MEN1 O00255 4/20 0.43
▸ KMT2A Q03164 4/20 0.43
▸ HIF1A Q16665 1/20 0.43
▸ KDM4E B2RXH2 4/20 0.43
▸ CYP1A2 P05177 3/20 0.43
▸ AGTR1 P30556 1/20 0.43
▸ ADRB2 P07550 4/20 0.42
▸ NMT2 O60551 2/20 0.42
▸ ADRB1 P08588 2/20 0.42
▸ ADRB3 P13945 2/20 0.42
▸ NMT1 P30419 2/20 0.42
▸ USP2 O75604 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6271437 0.90 GPR35 (0.42) GPR35LMNATDP1NQO1MEN1
SCHEMBL6276932 0.89 NQO1 (0.42) GPR35LMNATDP1NQO1MEN1
SCHEMBL6273064 0.88 GPR35 (0.41) GPR35LMNATDP1NQO1MEN1
SCHEMBL6272606 0.88 GPR35 (0.41) GPR35LMNATDP1NQO1MEN1
SCHEMBL6270379 0.88 GPR35 (0.41) GPR35LMNATDP1NQO1MEN1
SCHEMBL27582312 0.87 GPR35 (0.40) GPR35LMNATDP1NQO1MEN1
SCHEMBL6276681 0.86 PTGS1 (0.43) GPR35LMNATDP1NQO1MEN1
SCHEMBL6276689 0.85 GPR35 (0.40) GPR35LMNATDP1NQO1MEN1
SCHEMBL6274319 0.83 NQO1 (0.47) TDP1NQO1MEN1KMT2AKDM4E
SCHEMBL6276756 0.83 CYP1A2 (0.46) LMNAMEN1KMT2AKDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1273578-B1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK & CHEMICALS (JP) 2005-02-23 — — EP disclosed
CN-1473565-A Benzopyrany/derivatives and antiallergic agent ���ձ���ī��ѧ��ʽ���� 2004-02-11 — — CN disclosed
US-6670391-B2 For inhibiting both immediate and delayed type allergic reactions; side effect reduction DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-12-30 — — US disclosed
US-20030096860-A1 Benzopyran derivative and antiallergic agent DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-05-22 — — US disclosed
EP-1273578-A1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-01-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096860-A1 Benzopyran derivative and antiallergic agent HRH2, HRH1, HRH4 GPR35 136/4885LMNA 4503/4885TDP1 2417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback